0001558370-24-009211.txt : 20240614 0001558370-24-009211.hdr.sgml : 20240614 20240614171042 ACCESSION NUMBER: 0001558370-24-009211 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20240612 ITEM INFORMATION: Other Events FILED AS OF DATE: 20240614 DATE AS OF CHANGE: 20240614 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIO-PATH HOLDINGS, INC. CENTRAL INDEX KEY: 0001133818 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 870652870 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36333 FILM NUMBER: 241045909 BUSINESS ADDRESS: STREET 1: 4710 BELLAIRE BOULEVARD STREET 2: SUITE 210 CITY: BELLAIRE STATE: TX ZIP: 77401 BUSINESS PHONE: (832) 742-1357 MAIL ADDRESS: STREET 1: 4710 BELLAIRE BOULEVARD STREET 2: SUITE 210 CITY: BELLAIRE STATE: TX ZIP: 77401 FORMER COMPANY: FORMER CONFORMED NAME: BIO-PATH HOLDINGS INC DATE OF NAME CHANGE: 20080221 FORMER COMPANY: FORMER CONFORMED NAME: OGDEN GOLF CO CORP DATE OF NAME CHANGE: 20010205 8-K 1 bpth-20240612x8k.htm 8-K
0001133818false00011338182024-06-122024-06-12

​

​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

​

FORM 8-K

​

CURRENT REPORT PURSUANT

TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

​

Date of report (Date of earliest event reported): June 12, 2024

​

BIO-PATH HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

​

​

​

Delaware

    

001-36333

    

87-0652870

(State or other jurisdiction of incorporation)

​

(Commission File Number)

​

(IRS Employer Identification No.)

​

​

​

4710 Bellaire Boulevard, Suite 210, Bellaire, Texas

    

77401

(Address of principal executive offices)

​

(Zip Code)

​

(832) 742-1357

(Registrant’s Telephone Number, Including Area Code)

​

(Former Name or Former Address, if Changed Since Last Report)

​

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

​

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

​

Securities registered pursuant to Section 12(b) of the Act:

​

Title of each class

    

Trading Symbol

    

Name of each exchange on which registered

Common Stock, par value $0.001 per share

 

BPTH

 

The Nasdaq Capital Market

​

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

​

Emerging growth company ☐

​

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻

​

​

​

Item 8.01 Other Events.

​

As previously disclosed, on March 12, 2024, Bio-Path Holdings, Inc. (the “Company”) received a deficiency letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the minimum stockholders’ equity requirement of at least $2,500,000 for continued inclusion on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(b)(1) (the “Stockholders’ Equity Requirement”). On April 26, 2024, in accordance with Nasdaq Listing Rule 5810(c)(2)(A), the Company submitted a plan to Nasdaq to regain compliance (the “Compliance Plan”) with the Stockholders’ Equity Requirement.

​

On June 12, 2024, the Company received a letter from Nasdaq granting an extension (the “Extension Letter”) until September 8, 2024 to demonstrate compliance with the Stockholders’ Equity Requirement in accordance with the terms of the Extension Letter. If the Company does not demonstrate compliance in accordance with the Extension Letter, the Company may be subject to delisting. At that time, the Company may appeal Nasdaq’s delisting determination to a Nasdaq Hearings Panel (the “Panel”). If the Company timely appeals, it would remain listed pending the Panel’s decision.

​

The Company intends to continue making efforts to implement the Compliance Plan to regain compliance with the Stockholders’ Equity Requirement. However, there can be no assurance that the Company will be able to regain compliance with the Stockholders’ Equity Requirement within the allotted extension period. If the Company is unsuccessful in regaining compliance within the allotted extension period and appeals the delisting determination by Nasdaq to the Panel, there can be no assurance that such appeal will be successful.

​

​

​

​

SIGNATURES

​

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized.

​

 

BIO-PATH HOLDINGS, INC.  

 

 

 

​

​

​

Dated: June 14, 2024

By:

/s/ Peter H. Nielsen

 

 

Peter H. Nielsen

 

 

President and Chief Executive Officer

​

​

 EX-101.SCH 2 bpth-20240612.xsd EX-101.SCH 00090 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 bpth-20240612_lab.xml EX-101.LAB EX-101.PRE 4 bpth-20240612_pre.xml EX-101.PRE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Document and Entity Information
Jun. 12, 2024
Document and Entity Information [Abstract]  
Document Type 8-K
Document Period End Date Jun. 12, 2024
Entity File Number 001-36333
Entity Registrant Name BIO-PATH HOLDINGS, INC.
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 87-0652870
Entity Address State Or Province TX
Entity Address, Address Line One 4710 Bellaire Boulevard
Entity Address, Adress Line Two Suite 210
Entity Address, City or Town Bellaire
Entity Address, Postal Zip Code 77401
City Area Code 832
Local Phone Number 742-1357
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol BPTH
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Entity Central Index Key 0001133818
Amendment Flag false
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 1 23 1 false 0 0 false 0 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports bpth-20240612.xsd bpth-20240612_lab.xml bpth-20240612_pre.xml bpth-20240612x8k.htm http://xbrl.sec.gov/dei/2023 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "bpth-20240612x8k.htm": { "nsprefix": "bpth", "nsuri": "http://www.biopathholdings.com/20240612", "dts": { "schema": { "local": [ "bpth-20240612.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "bpth-20240612_lab.xml" ] }, "presentationLink": { "local": [ "bpth-20240612_pre.xml" ] }, "inline": { "local": [ "bpth-20240612x8k.htm" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 24, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation", "longName": "00090 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "Duration_6_12_2024_To_6_12_2024_azDJvkZz3E2CEmtyoO03Dg", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "bpth-20240612x8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_6_12_2024_To_6_12_2024_azDJvkZz3E2CEmtyoO03Dg", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "bpth-20240612x8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Document and Entity Information [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Adress Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address State Or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 14 0001558370-24-009211-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001558370-24-009211-xbrl.zip M4$L#!!0 ( %2)SEC*^V2Q>0, &4, 1 8G!T:"TR,#(T,#8Q,BYX MYB=H/#M)9^D8?;UK@7>@ M;\%>13[K8J;)BI88&:R6U'S&)=45)O1\M#*FFB7)>KV.YTQ6V*Q6DMNL=4QD MZ?C229:/$#9&L7EMZ">IRFNZP#4W4!GQJ\;1]U-X2,O-!R>/D\9:)GQXI,",Z ME* IB9?R*7&F@-:F,2"C-04.M5�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end XML 16 bpth-20240612x8k_htm.xml IDEA: XBRL DOCUMENT 0001133818 2024-06-12 2024-06-12 0001133818 false 8-K 2024-06-12 BIO-PATH HOLDINGS, INC. DE 001-36333 87-0652870 4710 Bellaire Boulevard Suite 210 Bellaire TX 77401 832 742-1357 false false false false Common Stock, par value $0.001 per share BPTH NASDAQ false